Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3073–3096 of 185,080 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: NOT program Clear all

Conditions: Advanced Breast Cancer
Interventions: ARV-471, Fulvestrant; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 87
States / cities: Encinitas, California • Fountain Valley, California • Fresno, California + 69 more

Conditions: SARS CoV 2 Infection
Interventions: Testing for SARS CoV2 Antigen; Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 99 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Arm Illness
Interventions: PROMIS Upper Extremity Function, Pain intensity, PROMIS depression, Positive affect negative affect scale (PANAS), standard PCS, positively-adjusted version of the PCS; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Heat Transfer by Clinical Warming Devices
Interventions: Adult blanket plus, MA2220 blanket connected to the Mistral Air, Blower MA1200-PM system., Premium adult blanket, 3320 blanket connected to the Mistral Air, Blower MA1200-PM system., Blanket full body, 30000 blanket connected to the 3M, Bair Hugger, Blower 775, FilteredFlo® Air Blanket connected to the WarmAir® Convective Warming system., Blanket Full Body blanket (CLM0101) connected to the Care Essential, Cocoon, Blower CWS5000 system; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Methamphetamine Use Disorders, HIV
Interventions: intermittent theta burst stimulation (iTBS), continuous theta burst stimulation (cTBS), Sham TMS; Device
Lead sponsor: Gopalkumar Rakesh; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Solid Tumors
Interventions: OMP-21M18; Drug
Lead sponsor: OncoMed Pharmaceuticals, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: Greenbrae, California • Stanford, California • Ann Arbor, Michigan

Conditions: Achalasia
Interventions: Achalasia subjects; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Common Cold, Pharyngitis, Fever, Congestion, Rhinorrhea, Cough, Sore-throat, Sore Throats Viral, Malaise, Headache, Runny Nose, Sneezing
Interventions: Wintergreen Throat Spray and Aspirin Tablet, Aspirin Throat Spray and Placebo Tablet, Wintergreen Throat Spray and Placebo Tablet, Placebo Throat Spray and Placebo Tablet; Drug · Dietary Supplement · Other
Lead sponsor: Applied Biological Laboratories Inc; Other
Eligibility: 18 Years to 65 Years
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 6
States / cities: Irvine, California • Washington D.C., District of Columbia • Atlanta, Georgia + 3 more

Conditions: Tobacco Use Disorder, Lung Cancer
Interventions: Non-intervention; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 55 Years to 74 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Sarcoma, Kaposi, HIV Infections
Interventions: Doxorubicin hydrochloride; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1990
U.S. locations: 12
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 7 more

Conditions: Brain Injury Traumatic Mild, Post-traumatic Stress Disorder
Interventions: Mindfulness-based Stress Reduction class, Brain Health Education class; Behavioral
Lead sponsor: East Bay Institute for Research and Education; Other
Eligibility: 18 Years to 75 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Martinez, California

Conditions: Mantle Cell Lymphoma
Interventions: Ibrutinib; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Opioid Misuse
Interventions: CPMRx; Behavioral
Lead sponsor: Jessica Morgan; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cannabis Use, Substance Use Disorder (SUD), Healthy
Interventions: Placebo Oral Capsule, THC; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 21 Years
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cancer, Metabolic Disease, Aneurysm, Neurologic Disorder
Interventions: MRI Scan; Diagnostic Test
Lead sponsor: Hercules; Industry
Eligibility: 18 Years and older
Enrollment: 100,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2037
U.S. locations: 1
States / cities: Watertown, Massachusetts

Conditions: AI Companionship
Interventions: AI Companion Interaction; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Heart Transplantation, Liver Transplantation, Kidney Transplantation
Interventions: FK506E; Drug
Lead sponsor: Astellas Pharma Europe Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Lipoma
Interventions: Deoxycholic Acid Injection, Placebo; Drug
Lead sponsor: Kythera Biopharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: San Diego, California

Conditions: Healthy Volunteer
Interventions: danoprevir, ketoconazole, ritonavir; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Seborrheic Keratosis
Interventions: A-101 Solution; Drug
Lead sponsor: Aclaris Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Malvern, Pennsylvania

Conditions: Airway Obstruction
Interventions: McMurray Enhanced Airway, Nasal Cannula; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Ulcerative Colitis
Interventions: Etrasimod, Placebo; Drug
Lead sponsor: Arena Pharmaceuticals; Industry
Eligibility: 16 Years to 80 Years
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 67
States / cities: Dothan, Alabama • Sun City, Arizona • Lancaster, California + 53 more

Conditions: Aphasia, Nonfluent Aphasia, Stroke
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 45 Years to 80 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Recurrent Melanoma, Stage IV Melanoma
Interventions: semaxanib, laboratory biomarker analysis; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

Rutgers Pilot for PREDICT- Patient POC Test

The Effect of Questionnaire Content on Measures of Pain Intensity, Magnitude of Disability, and Symptoms of Depression in Patients With Arm Illness

Heat Loss in Humans Covered With Full-Body Blankets Connected to Different Warming Devices

Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH

A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors

Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia

Alleviation of Common Cold Symptoms

Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma

Brain Health & Wellness Classes for Veterans With Traumatic Brain Injury

Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma

Decreasing Opioid Misuse and Habit-forming Behaviors Following Prescription in Patients Undergoing Cesarean Section

Research Investigating Drug Effects-2 (RiDE-2)

An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.

How Do Artificially Intelligent Companions Influence Psychological Outcomes?

Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant

Deoxycholic Acid Injection for the Treatment of Superficial Lipomas

A Study of RO5190591 (Danoprevir) in Healthy Volunteers

An Open-Label Safety Study of A-101 Solution

The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Neural Networks and Language Recovery in Aphasia From Stroke: fMRI Studies

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated